Fundz

Volastra Therapeutics reported raising $60.2 Million in an initial SEC Form D filing, from an offering of $60.2 Million

PRIVATEMar 13, 2023

Amount Raised

$60.2 Million

$60.2 Million sold, per SEC Form D (first sale Mar 3, 2023)

Round Type

Venture

New YorkBiotechnology

Quick answer

Volastra Therapeutics raised $60.2 Million in a funding round, dated March 3, 2023. Volastra Therapeutics is based in New York, New York, United States.

How much did Volastra Therapeutics raise?
Volastra Therapeutics raised $60.2 Million in a funding round on March 3, 2023.
What does Volastra Therapeutics do?
Volastra Therapeutics is a New York-based drug discovery and therapeutics company pioneering novel approaches to treating cancer by exploiting chromosomal instability (CIN), cancer’s most targetable vulnerability.
Where is Volastra Therapeutics based and how big is it?
Volastra Therapeutics is based in New York, New York, United States. Fundz records about 42 employees.
Who are the decision-makers at Volastra Therapeutics?
Fundz holds 2 contacts at Volastra Therapeutics, including the CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Volastra Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • inSoma Bio raised $1.1M (Seed) on April 17, 2023.
  • BioConsortia raised $15M on April 17, 2023.
  • Zetta Genomics raised $2.4M (Seed) on April 17, 2023.
  • Alucent Biomedical, Inc. raised $11M on April 17, 2023.
  • Smart Reporting raised $16M on April 17, 2023.
  • Cryomass Technologies raised $932K (Seed) on April 17, 2023.

Who to call at Volastra Therapeutics, and when

A new round usually means Volastra Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Volastra Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Volastra Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Volastra Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Volastra Therapeutics

Location

1361 Amsterdam Ave, 520

New York, New York, United States

About

Volastra Therapeutics is a New York-based drug discovery and therapeutics company pioneering novel approaches to treating cancer by exploiting chromosomal instability (CIN), cancer’s most targetable vulnerability. Founded by Lewis Cantley, Ph.D., Olivier Elemento, Ph.D., and Samuel Bakhoum, M.D., Ph.D., Volastra is advancing a novel synthetic lethal and immune activating pipeline. Leading its portfolio, Volastra has two KIF18A inhibitors in Phase 1 clinical trials for cancers with high levels of chromosomal instability.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Volastra Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsCharles H., CEOSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Volastra Therapeutics's next move

See what Strategic adds

Volastra Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.